Ding, Binyang
Yan, Jing
Shan, Xisheng
Deng, Mengkang
Qian, Jiajie
Du, Chentao
Zhang, Yang
Shen, Li
Ji, Fuhai
Pan, Tingrui
Funding for this research was provided by:
National Key Research and Development Program of China (2023YFC3603503, 2023YFC3603503, 2023YFC3603503, 2023YFC3603503, 2023YFC3603503)
Jiangsu Province Medical Research General Project (H2023019, H2023019, H2023019, H2023019, H2023019)
Suzhou Major Disease Multicentre Clinical Research Project (DZXYJ202401, DZXYJ202401, DZXYJ202401, DZXYJ202401, DZXYJ202401)
Article History
Received: 2 June 2025
Accepted: 14 August 2025
First Online: 1 October 2025
Declarations
:
: The authors declare no competing interests.
: This study was approved by the Ethics Committee of the Chinese Clinical Trial Register (Ref: ChiCTR2400089224) on 04/09/2024. Written informed consent was obtained from all participants involved in the study. This work was conducted in accordance with the Declaration of Helsinki.